| Today's Open | $265.79 |
|---|---|
| Previous Close | $263.64 |
| Daily Range | $263.49 - $269.78 |
| 52-Week Range | $107.31 - $283.99 |
| Market Cap | $25.9B |
| P/E Ratio | 35.41 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 536,285 |
| Average Daily Volume | 1,638,328 |
| Current FY EPS | $3.60 |
Sector
Healthcare
Industry
Drugs
Regeneron Pharmaceuticals, Inc. (REGN) Description
The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regn.com/
News & Commentary
Will ASCO Unlock Big Value in This Cancer Drug Class?
With the American Society of Clinical Oncology's annual meeting less than two weeks away, see what drug class could see big gains in the wake of new abstract data.Sanofi and Regeneron's Latest Partnership
Late-stage clinical trials begin for this duo's experimental rheumatoid arthritis drug.REGN's Top Competitors
(0.38%)
(1.29%)
(0.83%)
(1.98%)